Implementation of Home Monitoring in Patients With Pulmonary Fibrosis

Summary

The objective of this study is to evaluate the impact of structurally replacing half of the outpatient clinic visits for patients with pulmonary fibrosis by home monitoring and video consultations on patient self-management and health(care) outcomes.

Conditions

• Pulmonary Fibrosis
• Interstitial Lung Disease (ILD)

Interventions

COMBINATION_PRODUCT

Home monitoring care

Patients in the home monitoring group will receive a home spirometer, pulse oximetry meter, and access to a smartphone or tablet app, where they can perform home based measurements weekly and complete PROMs. Furthermore, this app includes disease specific information and allows for direct communication with the hospital via eConsultation. In the home monitoring group, half of the outpatient clinic visits will alternately be replaced by remote visits via video consultation.

Sponsors & Collaborators

• Zuyderland Medisch Centrum, Sittard-Geleen, the Netherlands

  collaborator UNKNOWN

• Leiden University Medical Center, LUMC, Leiden, The Netherlands

  collaborator UNKNOWN

• UMC Utrecht, Utrecht, the Netherlands

  collaborator UNKNOWN

• Rijnstate, Arnhem, the Netherlands

  collaborator UNKNOWN

• Catharina, Eindhoven, the Netherlands

  collaborator UNKNOWN

• MC Leeuwarden, Leeuwarden, the Netherlands

  collaborator UNKNOWN

• OLVG, Amsterdam, the Netherlands

  collaborator UNKNOWN

• Medical Center Haaglanden, The Hague, The Netherlands

  collaborator UNKNOWN

• Amphia, Breda, the Netherlands

  collaborator UNKNOWN

• St. Antonius Hospital

  collaborator OTHER

• Erasmus Medical Center

  lead OTHER

Principal Investigators

• Marlies S. Wijsenbeek-Lourens, Prof Dr · Department of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center, Rotterdam, The Netherlands

Study Design

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-10-02

Primary Completion

2026-09-01

Completion

2026-09-01

Countries

• Netherlands

Study Locations